Takudan I have found out how to buy those OTC Pink counters on IBKR.

It involves some "cheating".

You can read the reply from IBKR below:



It's rather funny that they group level 1 ADRs as penny stocks when Nestle and Roche are 200-300 billion USD companies.

But beware of liquidity risk though.

Nestle's ADR is still sponsored so it's up to the company to decide.

https://www.adr.db.com/drwebrebrand/dr-univ...?identifier=942

You can have a look at the link above to know more about it.

As for Chinese ADR, it depends on the SEC's decision. If they are not satisfied with Chinese's accounting standards and practices or could not get full access to the audit working papers, then it's the SEC's verdict whether to delist or not. Just follow the news.

If the ADR is delisted the money will be returned to you, or you can have it transferred to a new listing venue, depending on whether the company wants to list elsewhere.

Just a reminder for readers:

OTC markets can get very thin during crisis. Check the charts of those ADRs during 2008-2009 crisis from the Deutsche Bank website above, some even have no trades and no bids for the whole session back then, which means no one will buy from you at any price you are willing to sell. The bid-ask spread widens dramatically during such events.

You are strongly advised to purchase shares via primary exchanges in the home country whenever possible.

Caveat Lector.

For my case, most recent CHF deposit from Switzerland was just under 1 hour and 15 minutes. In that case Wise took 1 hour to verify with Credit Suisse for the money deposit, then some 10-15 minutes after Wise confirmed the money is received by CS, it appeared in my TWS portal ready to be invested.

USD and SGD case is around 1-2 hours.

For Switzerland stock investors:

https://www.wsj.com/articles/ubs-is-well-pr...share_permalink

UBS reports its 4Q 2021 results today: https://www.ubs.com/global/en/investor-rela...-reporting.html

Novartis to report earnings tomorrow before market open, conference call around 9 pm Malaysia time, followed by Roche the day after tomorrow at 2 pm (pre-market earnings release, conference call at 9 pm to 11 pm)

Novartis: https://www.novartis.com/investors/event-calendar
Roche: https://www.roche.com/investors/updates/inv...-2022-01-04.htm

Nestle will report results on 17th of February, with financial statements, corporate governance report and presentation slides available sharp at 2:15 pm Malaysia time. CEO virtual press conference will be held at 4pm Malaysia time while conference call will be held at 9pm Malaysia time.

Nestle: https://www.nestle.com/media/mediaeventscal...ll-year-results

This post has been edited by TOS: Feb 2 2022, 12:46 AM

Novartis Q4 result released.

https://www.novartis.com/investors/financia...arterly-results

https://www.businesstimes.com.sg/companies-...er-maker-orgain

Roche 4Q result released: https://www.roche.com/investors.htm

Not sure if anyone still have stakes in O&G companies these days. Shell's Q4 result just a moment ago: https://www.shell.com/investors/results-and...21/q4-2021.html

You are proprietary day trader (PDT)?

Can try Just ETF. https://www.justetf.com/en/

Otherwise just look for Vanguard and Blackrock websites and compare them manually. Normally you would just look at a few parameters like expense ratio etc., so can be done manually I guess.

Wah day trader

You use IB to day trade?

These are relevant to you then, I guess.

https://www.wsj.com/articles/shell-woos-fin...share_permalink

https://www.wsj.com/articles/energy-investo...share_permalink

Finally manage to buy 1 ROG share at 347.1. dwRK the spread if very high lah for the CFD data. I queue at 347 for very long but the CFD displays very low range of 346.6-346.8, thought something wrong with IBKR why my order didn't go through...

Luckily I buy with small amount for long term.

I just bought yesterday. Relax.

The dividends declared was 9.3 CHF, but it needs to be approved by shareholders in the AGM. So it can take some time. Withholding tax rate should be 35%, based on Swiss law, but if you are MY tax resident can enjoy discounted rates provided the postage fees are less than the withholding taxes refunded. I remember you asked this before.

And I am likely a HK tax resident now, so my rates are different from yours, but overall the reclaim methods should remain the same.

This post has been edited by TOS: Feb 4 2022, 01:15 PM

I didn't know you are a trader.

Unilever results: https://www.unilever.com/investors/results-...latest-results/

https://www.wsj.com/articles/unilevers-turn...share_permalink

This post has been edited by TOS: Feb 10 2022, 11:49 PM

Make sure you go through the list of CCP-related members behind those companies as well.

Good performance? Check its share price on Google finance haha

My picks may not be the same as yours. Even if they are the same, the proportions of these consumer non-discretionary and pharmaceutical shares which are defensive in nature may not be the same in your portfolio.

As for entry price. A simple analysis is to look for past PE trends and deduce whether the current/forward PE is in line or not. But this is just a first order approximation as share buybacks complicate the calculations (you don't know how much buybacks are done at a given time). In the end, fundamentals matter. Brand, market share etc. for consumer non-discretionary. And patent cliff, pipelines and potential M&A for big pharma.